chronic kidney disease/dialysis patient
Conditions
Interventions
Predilution OHDF (ABH-22PA) >
Washout period (2 hemodialysis) >
Hybrid OHDF (ABH-22PA) >
Predilution OHDF (ABH-22LA) >
Washout Period (2 hemodialysis) >
Hybrid OHDF (ABH-22LA)
Sponsors
Division of Clinical Engineering, Toujinkai Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: The patients with albumin of 3.5 g/dL or more who have been undergoing chronic maintenance dialysis therapy between March 2019 to April 2019 at the Toujinkai Hospital.
Exclusion criteria
Exclusion criteria: None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ten patients undergoing chronic maintenance dialysis therapy were included in this study. Four blood purification procedures were performed on the first day of each week's dialysis treatment: predilution OHDF using ABH-22LA (albumin leakage suppression type hemodiafilter), predilution OHDF using ABH-22PA (albumin leakage type hemodiafilter), hybrid OHDF using ABH-22LA, and hybrid OHDF using ABH-22PA. The dialyzed and filtered fluid drained during the 4-h session was collected and the concentrations of urea nitrogen, creatinine, inorganic phosphorus, beta2-microglobulin, alfa 1-microglobulin, and albumin were measured. From these, the removed amount and the clear space of each solute were calculated and were compared in hybrid OHDF and predilution OHDF. | — |
Countries
Japan
Contacts
Public ContactNaoki Suzuki
Toujinkai Hospital Clinical Engineering
Outcome results
None listed